AstraZeneca
AstraZeneca's Oncology R&D department is seeking a Cell Therapy Scientist to provide expertise in viral vectors and gene editing technologies for advancing cellular therapies. The role involves contributing to innovative research projects and supporting the development of next-generation immunotherapies.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Director of Vector Engineering and Manufacturing Quality - Cell Therapy
Marriott International
Scientist, CAR Discover
Eli Lilly and Company
Director, Business Development - Eastern U.S.
Landmark Bio
Scientist I, Cell and Molecular Biology, Gene Editing
Editas Medicine
Sr. Scientist - T-Cell Therapy Immunology
Regeneron Pharmaceuticals
Senior Scientist, Cell and Molecular Biology, Gene Editing
Editas Medicine